StockWatch
·
Specialty Chemicals
Quarterly Result2 Nov 2026, 01:57 pm

Epigral Ltd Declares Unaudited Financial Results for Q2 FY27

AI Summary

Epigral Limited announced its Unaudited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended September 30, 2026, following a Board Meeting held on November 2, 2026. The company also took on record the Limited Review Report issued by M/s. S R B C & CO LLP, Statutory Auditors. The meeting commenced at 12:00 Noon and concluded at 01:40 p.m. at the Registered Office in Ahmedabad.

Key Highlights

  • Board approved Unaudited Financial Results for Q2 and H1 FY27.
  • Limited Review Report from Statutory Auditors taken on record.
  • Results are both Standalone and Consolidated.
  • Board meeting held on November 2, 2026.
  • Meeting concluded at 01:40 p.m.